Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses.

[1]  Aaron M. Miller,et al.  Harnessing neoantigen specific CD4 T cells for cancer immunotherapy , 2020, Journal of leukocyte biology.

[2]  Cheryl F. Lichti,et al.  MHC-II neoantigens shape tumor immunity and response to immunotherapy , 2019, Nature.

[3]  S. Dhaliwal,et al.  CD8+ cytotoxic T cell responses to dominant tumor-associated antigens are profoundly weakened by aging yet subdominant responses retain functionality and expand in response to chemotherapy , 2019, Oncoimmunology.

[4]  K. Asha,et al.  Virus and tumor microenvironment induced ER stress and unfolded protein response: from complexity to therapeutics , 2018, Oncotarget.

[5]  Douglas E. V. Pires,et al.  DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability , 2018, Nucleic Acids Res..

[6]  M. Soler‐Lopez,et al.  Structure of Human Tyrosinase Related Protein 1 Reveals a Binuclear Zinc Active Site Important for Melanogenesis , 2017, Angewandte Chemie.

[7]  S. Gujar,et al.  Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines , 2017, Front. Immunol..

[8]  Jennifer G. Abelin,et al.  Mass Spectrometry Profiling of HLA‐Associated Peptidomes in Mono‐allelic Cells Enables More Accurate Epitope Prediction , 2017, Immunity.

[9]  A. Melcher,et al.  Immunogenicity of self tumor associated proteins is enhanced through protein truncation , 2016, Molecular therapy oncolytics.

[10]  Bo Zhang,et al.  Generation of influenza A viruses as live but replication-incompetent virus vaccines , 2016, Science.

[11]  Yong-Hui Zheng,et al.  Arms Race between Enveloped Viruses and the Host ERAD Machinery , 2016, Viruses.

[12]  A. K. Roos,et al.  University of Huddersfield Repository Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding , 2022 .

[13]  Morten Nielsen,et al.  Gapped sequence alignment using artificial neural networks: application to the MHC class I system , 2016, Bioinform..

[14]  S. Workenhe,et al.  Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  S. Rosenberg,et al.  T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy , 2013, Proceedings of the National Academy of Sciences.

[16]  Chi-Wei Chen,et al.  iStable: off-the-shelf predictor integration for predicting protein stability changes , 2013, BMC Bioinformatics.

[17]  M. Zanetti,et al.  Cell-Extrinsic Effects of Tumor ER Stress Imprint Myeloid Dendritic Cells and Impair CD8+ T Cell Priming , 2012, PloS one.

[18]  A. Melcher,et al.  Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma , 2012, Nature Biotechnology.

[19]  T. Alain,et al.  Virus-tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death. , 2011, Cancer cell.

[20]  C. Slingluff.  The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination? , 2011, Cancer journal.

[21]  S. Rosenberg,et al.  Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice , 2011, Clinical Cancer Research.

[22]  F. Errington,et al.  Broad Antigenic Coverage Induced by Viral cDNA Library-based Vaccination Cures Established Tumors , 2011, Nature Medicine.

[23]  M. Zanetti,et al.  Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells , 2011, Proceedings of the National Academy of Sciences.

[24]  A. Melcher,et al.  Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus. , 2011, Human gene therapy.

[25]  T. Wandless,et al.  A general chemical method to regulate protein stability in the mammalian central nervous system. , 2010, Chemistry & biology.

[26]  S. Steinberg,et al.  Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer , 2010, Cancer Immunology, Immunotherapy.

[27]  Sanjeev Gupta,et al.  Methods for Monitoring Endoplasmic Reticulum Stress and the Unfolded Protein Response , 2010, International journal of cell biology.

[28]  J. Boudreau,et al.  Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[29]  R. Vile,et al.  Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus. , 2007, Cancer research.

[30]  J. Schlom,et al.  Combining Vaccines with Conventional Therapies for Cancer. , 2007, Update on cancer therapeutics.

[31]  L. Banaszynski,et al.  A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules , 2006, Cell.

[32]  A. Houghton,et al.  Autoimmunity and tumor immunity induced by immune responses to mutations in self , 2006, Nature Medicine.

[33]  S. Jameson,et al.  Central tolerance: learning self-control in the thymus , 2005, Nature Reviews Immunology.

[34]  V. Engelhard,et al.  Regulated Folding of Tyrosinase in the Endoplasmic Reticulum Demonstrates That Misfolded Full-Length Proteins Are Efficient Substrates for Class I Processing and Presentation1 , 2005, The Journal of Immunology.

[35]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[36]  H. Andersson,et al.  Maximizing antigen targeting to the proteasome for gene-based vaccines. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  J. Adams,et al.  Development of the Proteasome Inhibitor Velcade™ (Bortezomib) , 2004, Cancer investigation.

[38]  O. Lund,et al.  novel sequence representations Reliable prediction of T-cell epitopes using neural networks with , 2003 .

[39]  Juan J Calvete,et al.  Crystal structure of a prostate kallikrein isolated from stallion seminal plasma: a homologue of human PSA. , 2002, Journal of molecular biology.

[40]  S. Perkins,et al.  Structural models for carcinoembryonic antigen and its complex with the single‐chain Fv antibody molecule MFE23 , 2000, FEBS letters.

[41]  V. Engelhard,et al.  The Density of Peptides Displayed by Dendritic Cells Affects Immune Responses to Human Tyrosinase and gp100 in HLA-A2 Transgenic Mice1 , 2000, The Journal of Immunology.

[42]  T. Morimoto,et al.  Endomembrane Trafficking of Ras The CAAX Motif Targets Proteins to the ER and Golgi , 1999, Cell.

[43]  A. Houghton,et al.  The cytoplasmic tail of the mouse brown locus product determines intracellular stability and export from the endoplasmic reticulum. , 1998, The Journal of investigative dermatology.

[44]  W. Heath,et al.  Defective TCR expression in transgenic mice constructed using cDNA‐based α‐ and β‐chain genes under the control of heterologous regulatory elements , 1998, Immunology and cell biology.

[45]  M. Hirose,et al.  Role of the intrachain disulfide bond of ovalbumin during conversion into S-ovalbumin. , 1996, Bioscience, biotechnology, and biochemistry.

[46]  S. Whelan,et al.  Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Leslie,et al.  Crystal structure of ovalbumin as a model for the reactive centre of serpins , 1990, Nature.

[48]  B. Coupar,et al.  Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen , 1988, The Journal of experimental medicine.